Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04584645 · ClinicalTrials.gov registry record · NA
A Digital Flu Intervention for People With Cardiovascular Conditions
A NA study, sponsored by Evidation Health.
- Completed
- Registry status
- NA
- Development phase
- 49,138
- Enrollment target
NCT04584645: Completed NA study, sponsored by Evidation Health.
NCT04584645 is a NA study that has completed, run by Evidation Health. The registered enrollment target is 49,138 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3402% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04584645, a NA study, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 49,138 participants
- Enrollment target
Study Summary
A 6-month prospective, digital randomized controlled trial targeting approximately 49,000 individuals to evaluate the effectiveness of an influenza vaccination intervention during influenza season for people with cardiovascular conditions
Primary Outcome
To determine the effectiveness of a digital intervention designed to increase influenza vaccination rates in individuals with cardiovascular diagnoses (CV diagnoses) by examining differences in self-reported influenza vaccination rates between individuals with cardiovascular disease who receive a targeted digital intervention (CVD-I) aimed at increasing influenza vaccination and those with CV diagnoses who received no intervention (CVD-C) by the end of the study period.
Interventions
- OTHER Targeted digital intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49,138 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2021-04-12 |
| Phase | NA |
What the finished NCT04584645 record still lists
NCT04584645 is an interventional study that assigns participants to a tested intervention. Its 49,138 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3402% higher).
The record links to 0 conditions, and to 1 intervention - of which Targeted digital intervention is the first listed.
NCT04584645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04584645 about?
NCT04584645 is a clinical study titled "A Digital Flu Intervention for People With Cardiovascular Conditions". A 6-month prospective, digital randomized controlled trial targeting approximately 49,000 individuals to evaluate the effectiveness of an influenza vaccination intervention during influenza season for people with cardiovascular conditions
What is the current status of trial NCT04584645?
This trial is currently completed. It is a NA study. The enrollment target is 49,138 participants. The study started on 2020-09-21. Estimated completion is 2021-04-12.
What interventions are being tested in trial NCT04584645?
The interventions under investigation include: Targeted digital intervention (OTHER).
Who is sponsoring clinical trial NCT04584645?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04584645's enrollment target sits among peer trials
49,138 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI